Kadant price target raised to $300 from $280 at Barrington

Barrington raised the firm’s price target on Kadant to $300 from $280 and keeps an Outperform rating on the shares. The firm cites a comparable trading analysis versus its peer group and its belief that 2024 will be a solid year for Kadant, with adjusted EBITDA accretion from both Key Knife and KWS.